Littlejohn & Co. LLC purchased a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 215,505 shares of the company’s stock, valued at approximately $1,846,878,000. Aveanna Healthcare accounts for 2.3% of Littlejohn & Co. LLC’s investment portfolio, making the stock its 8th largest position. Littlejohn & Co. LLC owned 0.10% of Aveanna Healthcare at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently bought and sold shares of AVAH. BlackRock Inc. purchased a new stake in shares of Aveanna Healthcare in the 2nd quarter worth $63,504,000. Vanguard Group Inc. increased its stake in shares of Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after buying an additional 1,535,351 shares during the period. Geode Capital Management LLC increased its stake in shares of Aveanna Healthcare by 17.7% during the fourth quarter. Geode Capital Management LLC now owns 1,849,057 shares of the company’s stock valued at $15,110,000 after buying an additional 278,429 shares during the period. Nuveen LLC raised its holdings in shares of Aveanna Healthcare by 135.9% in the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after acquiring an additional 905,316 shares in the last quarter. Finally, State Street Corp lifted its stake in Aveanna Healthcare by 20.9% in the fourth quarter. State Street Corp now owns 1,483,265 shares of the company’s stock worth $12,118,000 after acquiring an additional 256,392 shares during the period. Institutional investors own 87.96% of the company’s stock.
Aveanna Healthcare Stock Up 1.5%
NASDAQ:AVAH opened at $13.82 on Friday. The company’s 50-day simple moving average is $10.07 and its 200-day simple moving average is $8.08. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $14.00. The stock has a market capitalization of $3.02 billion, a P/E ratio of 11.24, a P/E/G ratio of 0.86 and a beta of 1.90.
Wall Street Analyst Weigh In
A number of research analysts have commented on the stock. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $10.00 to $11.00 in a research report on Friday, May 15th. Royal Bank Of Canada increased their price objective on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a research note on Monday. UBS Group boosted their price objective on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday, August 14th. Wall Street Zen lowered Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Finally, Raymond James Financial increased their target price on Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $12.89.
Read Our Latest Stock Report on AVAH
Insider Transactions at Aveanna Healthcare
In other news, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $143,704,885.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Paul R. Vigano sold 14,500,002 shares of the firm’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $166,750,023.00. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 79,746,745 shares of company stock valued at $773,117,091. Corporate insiders own 5.30% of the company’s stock.
About Aveanna Healthcare
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
See Also
- Five stocks we like better than Aveanna Healthcare
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
